Preeclampsia (PE) represents a major factor for maternal and perinatal morbidity and mortality [1] and it affects 7-10% of pregnancies worldwide [2] . PE is characterized by maternal syndromes such as gestational hypertension, proteinuria, oedema and foetal syndromes like reduced amniotic fluid, abnormal oxygenation and, in 30% of cases, intrauterine growth retardation (IUGR). The precise factors involved in the pathogenesis of PE remain unclear and it is considered as a multisystem disorder [1] . PE is principally characterized by impaired placentation and would be the result of an impaired differentiation of villous trophoblasts, which leads to an abnormal remodelling of the spiral arteries [3] . Diabetes, obesity, hypertension, renal disease, primiparity, maternal age, sperm and oocyte donation are all known predisposing factors for PE [1] . The oxidative stress, resulting from deficient remodelling of spiral arteries, is an important consequence of PE. It induces the placenta and a marker of oxidative stress (hOGG1 [Human 8-oxoguanine-DNA glycosylase 1]), as well as the influence of these variations on calcium transport in primary ST cultures. The mRNA and protein levels were thereby examined by real-time PCR and Western blot analysis, respectively, in two different groups of pregnant women with similar gestational age: a normal group (n ϭ 16) and a PE group (n ϭ 8), diagnosed by a clinician. Our study showed a significant decrease in calcium transport by the ST cultured from preeclamptic placentas. We found a significant (P Ͻ 0.05) decrease in mRNA levels of TRPV5, TRPV6, CaBP-9K, CaBP-28K, PMCA1, PMCA4, ATP synthase, IP3R1, IP3R2, RyR1, RyR2 and RyR3 in PE group compared to normal one. We also noted a significant decrease in protein levels of TRPV5, TRPV6, CaBP-9K, CaBP-28K and PMCA1/4 in PE group. In contrast, SERCA1, SERCA2, SERCA3, VDAC3 and hOGG1 mRNA expressions were significantly increased in PE placentas. Calcium homeostasis and transport through placenta is compromised in preeclamptic pregnancies and it appears to be affected by a lack of ATP and an excess of oxidative stress.
to release various factors, as inflammatory cytokines, apoptotic wastes and anti-angiogenic factors [4] . These secreted soluble factors are then thought to alter endothelial metabolic status, mitochondrial integrity and vascular functions [5] . Oxidation of DNA bases by endogenously generated and environmental reactive oxygen species (ROS) leads to mutations. Guanine is particularly prone to oxidation by ROS. 8-Oxo-deoxyguanine (8-oxo-dG) is a quantitatively major form of oxidative DNA damage [6, 7] , inducing mainly G (guanine) to T (thymine) and A (adenine) to C (cytosine) substitutions [8] . Human 8-oxoguanine-DNA glycosylase 1 (hOGG1) is the main enzyme that excises 8-oxo-dG from damaged DNA via the base-excision repair pathway [9] . It was suggested that cells under oxidative stress may require increased expression of hOGG1 to protect them from oxidative damageinduced mutations [10] .
In addition, during PE, the oxidative stress exposes the placenta to fluctuating oxygen concentration [11] and this periodic hypoxia will deplete placental cells from ATP. More precisely, it was observed that lower ATP levels in PE placental cells are due to an important change in expression of ATP synthase gene [12] , an important mitochondrial enzyme synthesizing ATP from ADP.
The most effective treatment for PE is delivery itself; however, several randomized trials reported the effective use of various methods to reduce the rate or severity of PE [1] , such as calcium (Ca   2ϩ   ) supplementation, but results showed minimum to no benefit. Several alterations in maternal Ca 2ϩ homeostasis were identified in PE, such as low urinary Ca 2ϩ excretion and low circulating level of 1,25-dihydroxyvitamin D3, parathyroid hormone-related peptide and calcitonin gene related peptide [13, 14] . Epidemiological data suggest an inverse correlation between dietary Ca 2ϩ uptake and incidence of hypertensive disorders of pregnancy in diverse populations [15] . Even if the results of two large clinical trials demonstrated disparity of the resulting benefits with respect to Ca 2ϩ supplementation in prevention of PE [16, 17] , Ca 2ϩ supplementation did reduce PE risk in high-risk pregnancies as well as for women with a low baseline dietary Ca 2ϩ uptake [18] . Ca 2ϩ is a universal intracellular second messenger involved in many processes such as signal transduction, neurotransmission, enzyme and hormone secretion, cell cycle regulation and programmed cell death. It is a crucial element for adequate foetal development and prenatal programming of future diseases. Ca 2ϩ is actively transported across the placenta at the rate of 140 mg/kg/day [19] to reach about 25-30 mg of Ca 2ϩ at term in the foetus. About 80% of the total foetal Ca 2ϩ is accumulated during the last trimester of pregnancy [20] . This Ca 2ϩ transfer allows adequate foetal skeleton mineralization [21] and various cellular functions. There are two pathways for Ca 2ϩ entry in the foetus.
Paracellular diffusion, active in perfused placental cotyledons, enables Ca 2ϩ to cross the placental barrier and represents 66% of the total maternal foetal transfer [22] . The second process involves transepithelial transport, which is mediated by the syncytiotrophoblast (ST). The ST is a polynucleated structure [23] formed during implantation and represents the most important maternal-foetal barrier [24] . The villous trophoblast cells are continuously incorporated, by syncytial fusion, into the ST. The ST is characterized by a brush border membrane facing maternal circulation and a basal plasma membrane facing the foetal circulation. Besides transport, the multifunctional properties of the ST include absorption, exchanges and specific hormonal secretion such as human chorionic gonadotropin (hCG) and human placental lactogen (hPL). Cytotrophoblasts isolated from human term placenta undergo spontaneous ST-like morphological and biochemical differentiation in vitro and are thought to resemble in vivo ST [25] . In a previous experiment, we quantified secretion of hCG, a wellknown marker of this differentiation process for a period of 7 days [25] , and interestingly, we observed that maximal hCG secretion was at day 4 of culture and paralleled the peak in Ca 2ϩ transport [26] . Intracellular Ca 2ϩ signalling pathway can be briefly described as extracellular stimulations of tyrosine kinase and G-protein-coupled receptors lunching cascade reactions leading to the production of the second messenger IP3 (inositol1-4, 5-triphosphate) [27, 28] . IP3 will bind to its receptor (IP3R) and Ca 2ϩ will be release from the endoplasmic reticulum (ER), trigger- [37] : a systolic blood pressure of 140 mmHg or higher or a diastolic blood pressure of 90 mmHg or higher on two occasions at least four hours apart, occurring after 20 weeks of gestation in a pregnant women with previously normal blood pressure, and detectable proteinuria (Ն0.3 g/24 hrs).This group also includes the late onset of PE characterized by the late manifestation of PE and excludes pregnancy with IUGR, SGA (small for gestational age) foetus or HELLP (haemolysis, elevated liver enzymes, low platelet count) syndrome. Four of our PE patients were treated with magnesium sulphate (MgSO4), safe for both mother and foetus [38] , which prevents seizures by altering membrane permeability and increasing seizure threshold [39] . Interestingly, MgSO4 infusion caused significant increases in ionized Mg ϩ2 levels, while serum ionized Ca 2ϩ concentrations were unchanged [40] , suggesting that the effect of MgSO4 is not exerted through modulations of ionized calcium levels [41] . Also, it was observed that in the normal pregnant women, ionized Ca 2ϩ levels were higher in foetal blood and that this same condition was found in PE women treated with MgSO4 [42], suggesting that this treatment has no effect on Ca 2ϩ transplacental transfer. Characteristics of pregnancies are summarized in Table 1 . From the placentas, maternal and foetal membranes were removed and small pieces of tissue from several cotyledons (5-10) were collected to have a good representation of the total placenta [43] . For RNA sample, tissues were embedded in RNA later stabilization reagent (Qiagen, Mississauga, Ontario, Canada), frozen in liquid nitrogen and stored at -80ЊC. Tissue samples for protein extraction were directly frozen into liquid nitrogen and subsequently transferred into sterile tubes for storage at -80ЊC.
Materials and methods

Placental tissues
RNA extraction and cDNA synthesis
RNA was isolated from total placenta (30 mg) using RNeasy mini kit extraction columns (Qiagen) and reverse-transcribed. After RNA isolation, 1 g of RNA was reverse transcribed into cDNA at 37ЊC for 1 hr using 10 M poly(dT) (Roche Applied Science, Laval, Qc, Canada), 0.5 mM dNTP and 4 U of Omniscript reverse transcriptase (Omniscript RT kit) (Qiagen) in a 20 l final volume. Exceptionally for the CaBP-28K gene, after reverse transcription, cDNA were first preamplified with the LightCycler RNA Pre-Amplification Kit (Roche Applied Science) before real-time PCR analyses.
Real-time PCR
Quantification of the mRNA coding for TRPV5, TRPV6, CaBP-9K, CaBP-28K, PMCA1, PMCA2, PMCA3 and PMCA4 was performed by real-time PCR using the Roche LightCycler 480 PCR (Roche Applied Science). All primer sequences (Table 2) were generated through Primer3 Input (http://fokker.wi.mit.edu/primer3/input.htm), verified for specificity by BLAST analyses and designed to span from two different exons. PMCA2 and PMCA3 primers were purchased from Qiagen, Inc. Real-time PCR reactions were performed in a volume of 10 l containing 1 l of cDNA, 1 M of each primer and 5 l of SYBR Green I Master (Roche Applied Science). Quantification of the endogenous ribosomal gene hypoxanthine phosphoribosyltransferase (HPRT)1 was performed to normalize variations in cDNA content among different samples. The expression of HPRT1 remained stable under our experimental conditions. Results were analysed with the LightCycler 480 software version 1.5, and melting curves were used to verify the specificity of the amplified products. Quantification of PCR products was performed through a standard curve generated by simultaneously amplifying serial dilutions of the corresponding cDNA. Values obtained for each gene were normalized to HPRT1 in the same sample.
Western blots analysis
Tissues were initially washed with lymphocyte lysis buffer containing 1.7 mM Tris-HCl (pH 7.3), 1.44 mM NH4Cl and protease inhibitor cocktail in tablets and then proteins were purified by the addition of the extraction buffer containing 125 mM Tris-HCl (pH 8.0), 2 mM CaCl2, 1.4% Triton X-100 (v/v) and protease inhibitor cocktail in tablets (Roche Applied Science). Protein concentrations were evaluated with BCA (bicinchoninic acid) assay (Pierce, Brockville, Ontario, Canada). Cellular proteins (100 g) were solubilized in Laemmli buffer and denatured by heating at 95ЊC for 5 min. Lysates were resolved in 10% SDS-PAGE and proteins were electro-blotted on a polyvinylidene difluoride (PVDF) membrane (Millipore, Cambridge, Ontario, Canada) at 17 V for 30 min. Membranes were blocked for 1 hr at room temperature in TBS-T (20 mM Tris (pH 7.6),
Characteristics
Normal group (n ‫؍‬ 16) PE group (n ‫؍‬ 8) Table 1 Clinical characteristics of mothers and babies Membranes were then incubated with the appropriate primary antibody (see Table 3 for details on antibodies) in TBS-T-3% bovine serum albumin (BSA) overnight at 4ЊC, washed three times with TBS-T and probed with horseradish peroxidase-conjugated secondary antibodies for 2 hrs at room temperature. Blots were washed three times with TBS-T and the detection was performed with the BM Chemiluminescence (POD) system (Roche Applied Science) and visualized on Kodak(tm) X-Omat™ Blue XB-1 autoradiography films from Perkin Elmer (Waltham, MA, USA). PVDF membranes were stripped with a stripping solution containing 25 mm glycine-HCl (pH 2) and 1% SDS at room temperature for 10 min., rinsed twice with PBS (10 mM sodium phosphate (pH 7.2) and 0.9% NaCl) and blocked for 1 hr before reprobing with another antibody. Precisely, we loaded eight samples/gel (eight normal ϩ eight PE) and transferred two gels/membrane. After exposure, membranes were stained with Amido Black Staining Solution (Sigma) to correct variations in protein content among samples. Densitometric analysis of band intensities was made with QuantityOne Bio-Rad (Hercules, CA, USA) software and results were normalized with protein content obtained by Amido Black. 
Cell cultures
For Ca 2ϩ transport assay, primary cytotrophoblast cells were prepared from placentas obtained immediately after vaginal delivery, from normal term pregnancies (n ϭ 5) and from PE pregnancies (n ϭ 4) (see characteristics in Table 1 ). Cytotrophoblast cells were isolated using the trypsin (Sigma)-DNase (Roche Applied Science)/Percoll (Sigma) method as described by Kliman et al. [25] , with some modifications [44] . Following cell isolation, cytotrophoblast cells were seeded at a density of 1.5 ϫ 10 6 cells per well in 24-well plate (Corning, Acton, USA) and maintained in Dulbecco's modified Eagle's medium (high glucose) (DMEM-HG) (Sigma) containing 10% FBS (Cansera International Inc, Etobicoke, Ontario, Canada), 2 mM glutamine (Gibco-Invitrogen, Burlington, Ontario, Canada), 25 mM HEPES (Sigma) and PSN, a penicillin-streptomycin-neomycin antibiotic mixture (Gibco-Invitrogen). The medium was refreshed daily. The purity of the cytotrophoblast cell preparation was evaluated by flow cytometry using FITC-conjugated monoclonal antibody against cytokeratin-7 as previously described [44] .
MTT Assay
The cells viability was measured by the MTT assay (Sigma). Cells were cultured with DMEM-HG without phenol red and were incubated with 100 l MTT per well each day. Plates were incubated for 1 hr at 37ЊC and 200 l of DMSO were added to each well. After mixing,, the optical density was measured at 570 nm. 
Ca
2؉ transport assay
Statistical analyses
Data were expressed as the mean Ϯ S.E.M. and were analysed using GraphPad Prism software for windows, version 5.0. One-way ANOVA followed by the Tukey's test was used to analyse Ca 2ϩ transport and nonparametric Mann-Whitney U-test was used to determine differences in mRNA and protein levels between normal and PE placentas. A P-value Ͻ 0.05 was considered statistically significant. (Fig. 1A) . To make sure that the Ca 2ϩ transport in PE cultures was not affected by a probable higher rate of apoptosis, we measured the cells viability in the two cellular populations and there was no difference between normal and PE trophoblast cells (Fig. 1B) . These observations suggest strongly that in PE, Ca 2ϩ transfer by ST is compromised. To study whether the decreased calcium transport in placentas from PE women is due to a decrease of calcium-handling protein in ST, we extracted mRNA and proteins from total placental tissues and we compared the changes in protein and mRNA levels, by Western blot and real-time PCR, of several genes implicated in placental Ca 2ϩ transport in normal and PE placentas.
Results
Ca
TRPV5 and TRPV6 expression is decreased in PE
To establish if the entry of calcium in the placenta is disturbed during PE, we examined the protein and mRNA expression of TRPV5 and TRPV6, gatekeepers of Ca 2ϩ transport. We found that the protein expression of TRPV5 was significantly decreased in PE compared to normal placental tissues ( Fig. 2A) , as its mRNA expression (Fig. 2B) . Similarly, TRPV6 protein and mRNA expression decreases in PE compared to normal group (Fig. 2C, D) . These findings suggest that the decrease in the Ca 2ϩ transport in ST is partially due to an impaired entrance in the placenta.
CaBP-9K and CaBP-28K expression is decreased in PE
Immediately after its penetration in the ST, Ca 2ϩ moves toward the foetal side, where it is extruded, or it is buffered to avoid reaching lethal concentration for the cell. Those tasks are accomplished by calcium binding proteins, as CaBP-9K and CaBP-28K. To verify if this system is altered in PE, we analysed their protein and mRNA expression. We found that the protein expression of CaBP-9K is decreased in the PE placental tissue compared to normal ones (Fig. 3A) as well as mRNA expression (Fig. 3B) . For the gene CaBP-28K, the protein and mRNA expression is also decreased in PE placentas (Fig. 3C, D) . These observations suggest that Ca 2ϩ buffering is altered in PE placental cells.
PMCAs expression is decreased in PE
Once arrived on the other side of the cell, Ca 2ϩ has to cross over a last membrane to reach the foetal circulation. This expulsion is mainly achieved by the ATPase pumps PMCAs, which respond to foetal specific needs in calcium. To determine if an impaired Ca 2ϩ exit from ST could be responsible for the impaired placental transfer seen in Fig. 1 , we studied protein and mRNA levels of 4 isoforms of PMCA (PMCA1-4). For the protein expression, we used an antibody that detects PMCA1 and PMCA4 together. Thus, we observed that the protein expression of PMCA 1/4 ( Fig. 4A ) decreases significantly in PE compared to normal group. We observed a similar pattern for PMCA1 and PMCA4 mRNA expression (Fig. 4B, C) . In contrast, PMCA2 and PMCA3 mRNA expressions show no variation (data not shown). Collectively, these 
ATP synthase level is decreased in PE
PMCAs are ATPase pumps, thus they need ATP to function properly. As it was observed that lower ATP levels in PE placental cells is due to an important change in expression of ATP synthase gene [12] , we wanted to verify if that phenomenon was present in our tissue samples and if it could be the cause of the reduction of PMCAs. Therefore, we analysed mRNA levels of the mitochondrial ATP synthase gene in normal and PE placental tissues (Fig. 5) . We observed that its mRNA expression was drastically decreased PE compared to normal. This result suggests, as we suggested, that depletion of ATP by hypoxia affect PMCAs expression in PE tissues.
Ca
2؎ intracellular signalling implicating mitochondria and ER is altered in PE
Following the decrease of CaBPs (Fig. 3) and PMCAs (Fig. 4 ]i. Unsurprisingly, we obtained an increase in mRNA of SERCA gene in PE placentas (Fig. 8) . Likewise, the mitochondria is another important organelle that stores Ca 2ϩ and as its replenishment implicates VDAC gene, we analysed its mRNA expression and also observed a significant increase in PE placentas (Fig. 9) . These results support our hypothesis about the alteration of intracellular Ca 2ϩ signalling in placentas with PE, more precisely of Ca 2ϩ overload.
Presence of high hOGG1 mRNA expression: PE placentas undergo severe oxidative stress hOGG1 is an enzyme repairing DNA oxidation damages by excising oxidized-guanine. As the presence of elevated levels of hOGG1 correlates with elevated ROS levels, we analysed its mRNA expression to determine, as we suggested, if PE placentas are more affected by oxidative stress than normal ones. Interestingly, we observed a huge increase of hOOG1 mRNA expression in PE placentas (Fig. 10) . This result confirms that in PE, placental cells suffer from severe oxidative stress, which surely alters many cellular mechanisms, as Ca 2ϩ signalling.
Discussion
In this study, we demonstrated for the first time a significant decrease in Ca 2ϩ transport in primary cultures of ST from PE placentas compared to uncomplicated ones. As we show in Fig. 1 , Ca 2ϩ transport is about 60% lower in primary PE ST cells than in normal. Earlier, we and others demonstrated that, after 4 days of culture, there was a significant reduction of 40% in cell fusion in trophoblasts isolated from PE placentas when compared to The number of placentas tested for the mRNA expression is shown in parentheses for (B) and (D). For protein and mRNA expression, data were normalized according to amido black total protein levels and to HPRT1 housekeeping gene, respectively. *P Ͻ 0.05.
trophoblasts obtained from normal patients (unpublished data). Thus, the decrease in Ca 2ϩ transport from ST is only partially due to the 40% reduction of syncytial volume seen in primary ST from PE (unpublished data). To explain what may also be responsible for the altered Ca 2ϩ transfer and to clarify the mechanism involved, we investigated the expression of different proteins involved in Ca 2ϩ homeostasis in placentas from PE pregnancies.
Until now, there is no information on the variation of the Ca 2ϩ handling proteins and the Ca 2ϩ transfer in PE placentas. Importantly, for the first time, we successfully quantified the placental mRNA expression of CaBP-28K by real-time PCR. Herein, we demonstrated that the Ca 2ϩ homeostasis is perturbed in PE placentas, most likely caused by a high oxidative stress level and lack of ATP.
Decreased expression of TRPVs is accompanied with a decreased expression of CaBPs
A recent study shown that the Ca 2ϩ concentration in foetal blood and amniotic fluid is significantly lower in murine TRPV6 knockout (KO) foetuses than in wild-types [45] . The same team also demonstrated that the transport activity of radioactive Ca 2ϩ (   45   Ca   2ϩ ) from mother to foetuses was 40% lower in TRPV6 KO For protein and mRNA expression, data were normalized according to amido black total protein levels and to HPRT1 housekeeping gene, respectively. *P Ͻ 0.05. foetuses than in wild-types, that TRPV6 and CaBP-9K co-localized in the yolk sac and that CaBP-9K mRNA expression was decreased in TRPV6 KO mice placentas [45] . Also, TRPV6 expression has been shown to increase with the induction of CaBP-9K [46] . These data suggest an important role for the TRPV6 channel in Ca 2ϩ homeostasis and placental transfer, and suggest that TRPV6 and CaBP-9K are cooperatively involved in maternal-foetal Ca 2ϩ transport. This matches with our results, as we obtained a decrease in transport of 45 Ca 2ϩ in ST from PE placentas (Fig. 1A) , accompanied by a decrease of TRPV6 (Fig. 2D ) and CaBP-9K (Fig. 3B) protein and mRNA expression. Mice TRPV5 KO have shown a defective Ca 2ϩ homeostasis, limited Ca 2ϩ transfer to the foetus, as well as a CaBP-28K mRNA down regulation [47] . Moreover, a previous report showed that CaBP-28K translocates towards the plasma membrane and directly associates with TRPV5, facilitating high calcium transport rates by preventing channel inactivation [48] . In our study, we also observed a decreased mRNA and protein expression of TRPV5 ( Fig. 2A, B) accompanied by a decreased mRNA and protein expression of CaBP-28K (Fig. 3C, D) . It has been demonstrated that TRPV5 and TRPV6 are considered as gatekeepers of transcellular Ca 2ϩ transport as they are inversely correlated with the intracellular Ca 2ϩ concentration [49] . Effectively, it was demonstrated that in condition of high Ca 2ϩ concentration, both TRPV5 and TRPV6 exhibit calcium-dependant inactivation to avoid elevation in intracellular calcium to toxic levels [46] . This is the first time that the correlation of the expression of TRPVs with CaBPs is observed in human placentas, suggesting a fundamental role of CaBPs in the regulation of TRPVs. Moreover, it has also been demonstrated that CaBP-28K binds to the amino and carboxyl end of both TRPV5 and TRPV6 in low calcium concentration and that the disruption of this association results in a decrease of Ca 2ϩ buffering at the entry gate, followed by impairment of transcellular Ca 2ϩ transport [48] .
Finally, a synchronized rise in the expression of both TRPV5/TRPV6 and intracellular CaBP-9K/28K is essential to achieve maximal Ca 2ϩ influx at the apical side, which seems to be deficient in placentas with PE.
PE placentas demonstrate a decreased expression of PMCA1 and 4 as well as an increase of ATP synthase and hOGG1 genes
In Ca 2ϩ transport, the importance of CaBPs is also highlighted by its co-expression with PMCA1 [48] . In human placentas, PMCAs are the principal proteins implicated in Ca 2ϩ extrusion to the foetal side from the ST. Their function is to eliminate intracellular calcium in excess, and, at a resting state, maintain cytosolic calcium concentration to prevent toxic surcharge [50] . To be functional, PMCAs need the presence of ATP. It was shown that ATP level in PE placental cells is lower due to an important change in ATP synthase gene [12] and we demonstrated that the ATP synthase level in our tissue samples was significantly decreased in PE (Fig. 5) . Moreover, it was shown that changes in PMCA expression was correlated with its activity and ATP content in rat cells [51] . This agrees with our results where we observed a significant decrease in mRNA and protein expression of PMCA1 and 4 (Fig. 4) . This lack of ATP is possibly attributed to hypoxia in PE placenta, caused by oxidative stress, which would deplete cellular ATP. To determine if there was a real increased of ROS in our samples, we analysed the mRNA expression of hOGG1, a marker of oxidative stress. Effectively, mRNA expression on hOGG1 is extremely higher in PE placental tissue than in normal (Fig. 10) . Indeed, oxidative stress, resulting of deficient spiral artery remodelling, is an element of PE acting as a key intermediary event in the pathology [52] . Thus, based on the reduced mRNA and protein expression of PMCA1 and 4 in PE placentas, we suggest that this could result in inefficient calcium exclusion from ST by PMCAs. Moreover, the oxidative stress in PE placenta promotes the formation of lipids peroxides, which alter cell membranes, where, as we known, are located the PMCAs [52] . It was recently demonstrated the PMCA activity is very sensitive to the level of lipid peroxidation of the plasma membrane [53] and that the reduced activity of PMCAs in PE women could not be associated with a defective enzyme but rather with a high level of lipid peroxidation [54] . It also has been demonstrated that oxidative stress induces a Ca 2ϩ overload response and inhibition of PMCAs in rat pancreatic cells [55] . A recent study indicated that the inhibitory effect of both oxidative stress and mitochondrial inhibitors on PMCA activity was explained by ATP depletion due to the inhibition of mitochondria [56] . That information could suggest that PMCAs are negatively affected by the depletion of ATP caused by oxidative stress in PE, which in consequence will increase the intracellular calcium concentration. This rise in Ca 2ϩ content could affect mitochondria and contribute to the rise of apoptotic events, accentuating the ATP depletion.
Avoiding Ca 2؎ overload by the action of ER and mitochondria
Besides the action of CaBPs, the major mechanisms known to avoid excessive calcium concentrations in the cell are the buffering action of the ER and the mitochondria. It is well known that ER, a specialized calcium store organelle, is intimately involved in regulating Ca 2ϩ movements within cells. IP3Rs and RyRs participate in the release of Ca 2ϩ from the ER [29, 30] and we observed that the mRNA expression of IP3R1,2 ( Fig. 6 ) and RyR1,2,3 ( Fig. 7) was decreased in PE placentas. Thus, we suggest that this decrease is a consequence of elevated [Ca 2ϩ ]i. In contrast, we observed that SERCA1,2,3 ( Fig. 8) ]i [34] . In parallel, we also observed that the mRNA expression of VDCA3 (Fig. 9) , channel implicated in mitochondrial Ca 2ϩ accumulation, increased in PE placentas.
In conclusion, the important finding of this study is the alteration of the calcium transfer in PE placentas compared with normal placentas. Another important finding in this work was the successful quantification of the CaBP-28K mRNA by real-time PCR. Based on our results and recent works, we can hypothesize that oxidative stress in PE is a determinant factor affecting calcium transfer in ST. As we demonstrated, the decrease of PMCA expression could be attributed to the ATP depletion, probably caused by oxidative stress, and in consequence, elevates intracellular Ca 2ϩ concentration, which in turn down-regulates CaBPs, TRPVs. We also propose that IP3Rs and RyRs expression decrease, while SERCAs and VDACs increase in order to avoid a Ca 2ϩ overload. In perspectives, as placental insufficiency could lead to IUGR in 30% of the cases [2] , which is associated with lower cord blood calcium concentration [57] , it could be interesting to compare the mechanisms of calcium transfer in PE placentas with or without IUGR. Working on strategies to protect placentas against reduced expression of PMCA may be very useful to weaken symptoms related to oxidative stress and intracellular calcium overload, and to enhance Ca 2ϩ transfer to the foetus. By elucidating factors involved in the placenta Ca 2ϩ transport in pregnancy, we will be able to determine one of the possible mechanisms responsible for foetal predisposition to adult diseases related to PE. This fundamental approach will not have an immediate impact in clinical practice, but it will help to characterize the Ca 2ϩ transfer process from mother to foetus in these pregnancies and evaluate if ultimately it will be possible to improve antenatal placental transfer using nutritional intervention, pharmacological or hormonal agents. This project is the first step of a project of great magnitude. Future studies are needed to investigate the mechanism of placental Ca 2ϩ transport in PE and in several years, we shall perhaps be able to intervene to develop strategies before birth to improve foetal and neonatal health using nutritional, pharmacological or hormonal intervention.
